$1.81
-0.13-6.70%
At Close: -
$1.90
0.094.97%
After Hours: 4:15 PM EDT
15 minutes delayed
Verrica Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Verrica Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-0.31 | $-0.42 | 26.2 % |
Mar 2024 | 2024-05-13 | $-0.38 | $-0.40 | 5.00 % |
Dec 2023 | 2024-02-29 | $-0.53 | $-0.53 | 0.00 % |
Sep 2023 | 2023-11-09 | $-0.32 | $-0.36 | 11.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $5.18M | $4.37M | 18.5 % |
Mar 2024 | 2024-05-13 | $3.83M | $2.78M | 37.6 % |
Dec 2023 | 2024-02-29 | $1.99M | $910.00K | 118.5 % |
Sep 2023 | 2023-11-09 | $2.92M | $510.00K | 472.0 % |
Verrica Pharmaceuticals (VRCA) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.31, which beat the estimate of $-0.42.
The Actual Revenue was $5.2M, which beat the estimate of $4.4M.
Browse earnings estimates, EPS, and revenue on all stocks.